Link Pharma Chem Limited (BOM:524748)
25.00
+0.99 (4.12%)
At close: Jul 31, 2026
Link Pharma Chem Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 111 | 101 | 150 | 187 | 163 | 179 | |
Market Cap Growth | -30.07% | -32.98% | -19.67% | 14.97% | -9.04% | 70.19% |
Enterprise Value | 178 | 166 | 214 | 254 | 226 | 149 |
Last Close Price | 25.00 | 22.66 | 33.81 | 42.09 | 36.61 | 40.25 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 144.36 | 130.85 | - | - | 24.85 | 9.50 |
PS Ratio | 0.40 | 0.37 | 0.59 | 0.63 | 0.42 | 0.33 |
PB Ratio | 0.87 | 0.79 | 1.19 | 1.36 | 1.08 | 1.24 |
P/TBV Ratio | 0.87 | 0.79 | 1.19 | 1.36 | 1.08 | 1.24 |
P/FCF Ratio | 238.23 | 215.93 | 6.18 | - | - | - |
P/OCF Ratio | 5.17 | 4.69 | 5.59 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.65 | 0.61 | 0.84 | 0.85 | 0.58 | 0.28 |
EV/EBITDA Ratio | 12.00 | 11.17 | 166.22 | - | 8.31 | 4.26 |
EV/EBIT Ratio | 35.28 | 32.85 | - | - | 12.59 | 5.79 |
EV/FCF Ratio | 382.36 | 356.01 | 8.81 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.57 | 0.57 | 0.46 | 0.67 | 0.58 | 0.44 |
Debt / EBITDA Ratio | 4.92 | 4.92 | 44.93 | - | 3.22 | 1.82 |
Debt / FCF Ratio | 156.74 | 156.74 | 2.38 | - | - | - |
Net Debt / Equity Ratio | 0.53 | 0.53 | 0.45 | 0.67 | 0.58 | 0.42 |
Net Debt / EBITDA Ratio | 4.52 | 4.52 | 44.43 | -14.09 | 3.19 | 1.75 |
Net Debt / FCF Ratio | 144.13 | 144.13 | 2.35 | -9.36 | -3.33 | -2.53 |
Asset Turnover | 1.14 | 1.14 | 1.03 | 1.02 | 1.26 | 1.95 |
Inventory Turnover | 2.10 | 2.10 | 2.16 | 1.87 | 2.61 | 10.26 |
Quick Ratio | 0.52 | 0.52 | 0.51 | 0.47 | 0.26 | 0.54 |
Current Ratio | 1.01 | 1.01 | 1.11 | 1.05 | 1.21 | 1.28 |
Return on Equity (ROE) | 0.60% | 0.60% | -7.79% | -9.48% | 4.43% | 13.92% |
Return on Assets (ROA) | 1.31% | 1.31% | -2.07% | -3.60% | 3.65% | 5.85% |
Return on Invested Capital (ROIC) | 1.47% | 1.52% | -3.95% | -7.23% | 5.98% | 11.56% |
Return on Capital Employed (ROCE) | 3.70% | 3.70% | -6.10% | -11.30% | 10.00% | 14.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.69% | 0.76% | -6.84% | -7.29% | 4.02% | 10.53% |
FCF Yield | 0.42% | 0.46% | 16.18% | -5.23% | -15.99% | -13.51% |